Experts Discuss Effects of Cancer on Memory and Thinking at Free Symposium
CINCINNATIThe University of Cincinnati Cancer and Neuroscience Institutes are holding a free seminar Saturday, Sept. 12, to educate patients and the community on the effect of cancer therapy on memory loss and critical thinking.
The event, which will take place from 8 a.m. to noon, will involve presentations from and interactive discussions with oncology and neuroscience experts.
"The diagnosis of cancer is accompanied by fear and uncertainty, and while much of the focus is on the prognosis of the disease, the perceived effects of the treatment also cause a great deal of anxiety, says Luke Pater, MD, a UC Health radiation oncologist, assistant professor at UC and member of the institutes who is speaking at the event.
"Neurocognitive effects of anti-cancer therapies have long been recognized. The term chemobrain has been assigned to cognitive delays that patients experience following the administration of chemotherapy. A greater understanding of how different doses of radiation and exposures to different regions of the brain have evolved which has led to new approaches in how patients are treated to minimize side-effects on memory and cognition.
"We hope that this event will educate patients on advances being made in this regard and allow them to ask questions about both cancer treatment and effects.
In addition to a presentation by Pater which will focus on ways to minimize cognitive changes after radiotherapy, experts will discuss memory loss and cancer, mood and mental functioning, the effect of chemotherapy on the brain and ways to minimize cognitive changes after radiotherapy. A free continental breakfast will be offered for attendees.
>> See the full agenda and register
With questions, contact Karen Ramos at 513-558-1530.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.